Patent ID: 11939335
Assignee: 858 THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC A  C

Claim 9:
10. The compound of claim 9, or a pharmaceutically acceptable salt, deuteroisotope, or stereoisomer thereof, wherein R1 is CH2(heteroaryl), wherein the heteroaryl portion of CH2(heteroaryl) is optionally substituted with one or more substituents independently selected from the group consisting of D, halo, CN, NO2, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, C(O)Ra, C(O)N(Ra)2, C(O)ORa, N(Ra)2, NRaC(O)Ra, NRaC(O)ORa, NRaS(O)tRa, ORa, OC(O)Ra, OC(O)N(Ra)2, OC(O)ORa, ORcC(O)N(Ra)2, S(O)tRa, S(O)tN(Ra)2, S(O)tORa, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl.